These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10584568)

  • 1. [Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline].
    Nagai S; Toi M; Kuroi K; Hayashi K; Tominaga T
    Gan To Kagaku Ryoho; 1999 Nov; 26(13):2037-42. PubMed ID: 10584568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer.
    Nabholtz JM; Thuerlimann B; Bezwoda WR; Melnychuk D; Deschênes L; Douma J; Vandenberg TA; Rapoport B; Rosso R; Trillet-Lenoir V; Drbal J; Aapro MS; Alaki M; Murawsky M; Riva A
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):25-30. PubMed ID: 9364538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel in patients with anthracycline-resistant advanced breast cancer.
    Vici P; Belli F; Di Lauro L; Amodio A; Conti F; Foggi P; Gionfra T; Morelli MF; Botti C; Ferraironi A; Lopez M
    Oncology; 2001; 60(1):60-5. PubMed ID: 11150910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel vs doxorubicin in metastatic breast cancer resistant to alkylating chemotherapy.
    Chan S
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):19-24. PubMed ID: 9364537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Docetaxel therapy against anthracycline resistant breast cancer].
    Oura S; Sakurai T; Yoshimura G; Tamaki T; Umemura T; Kokawa Y; Naito Y; Suzuma T; Tanino H
    Gan To Kagaku Ryoho; 1999 May; 26(6):781-8. PubMed ID: 10410147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two cases of recurrent breast cancer successfully treated with paclitaxel weekly therapy].
    Tagaya N; Nakagawa A; Okada T; Hamada K; Mikami H; Ito S; Kubota K
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1479-83. PubMed ID: 14584281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel is a potent cytotoxic drug in the treatment of advanced breast cancer.
    Van Vaerenbergh W; Paridaens R; Thomas J; Wildiers J; Van Oosterom A
    Acta Clin Belg; 1998 Aug; 53(4):264-9. PubMed ID: 9795447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Docetaxel].
    Suzuki Y; Tokuda Y
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1363-7. PubMed ID: 11681243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent breast cancer].
    Taguchi T; Mori S; Abe R; Hasegawa K; Morishita Y; Tabei T; Sasaki Y; Fujita M; Enomoto K; Hamano K
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2625-32. PubMed ID: 7979423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel as neoadjuvant chemotherapy in patients with stage III breast cancer.
    Gradishar WJ
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):15-8. PubMed ID: 9364536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of docetaxel for anthracycline-resistant metastatic breast cancer].
    Ikeda H; Koshiba R
    Gan To Kagaku Ryoho; 2001 May; 28(5):637-41. PubMed ID: 11383211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
    Kouroussis C; Agelaki S; Mavroudis D; Souglakos J; Kakolyris S; Kalbakis K; Vardakis N; Reppa D; Hatzidaki D; Samonis G; Georgoulias V
    Cancer Chemother Pharmacol; 2000; 46(6):488-92. PubMed ID: 11138462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer.
    Nabholtz JM; Smylie M; Mackey JR; Noel D; Paterson AH; al-Tweigeri T; Au D; Sansregret E; Delorme F; Riva A
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):37-41. PubMed ID: 9364541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.
    Gennari A; Guarneri V; Landucci E; Orlandini C; Rondini M; Salvadori B; Ricci S; Conte PF
    Clin Breast Cancer; 2002 Dec; 3(5):346-52. PubMed ID: 12533265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
    Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
    Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-induced remission in docetaxel-refractory anthracycline-pretreated metastatic breast cancer.
    Suzuma T; Sakurai T; Yoshimura G; Umemura T; Tamaki T; Naito Y
    Anticancer Drugs; 2000 Aug; 11(7):569-71. PubMed ID: 11036960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.
    Valero V; Holmes FA; Walters RS; Theriault RL; Esparza L; Fraschini G; Fonseca GA; Bellet RE; Buzdar AU; Hortobagyi GN
    J Clin Oncol; 1995 Dec; 13(12):2886-94. PubMed ID: 8523051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly docetaxel as second-line therapy for patients with advanced breast cancer resistant to previous anthracycline treatment.
    Ramos M; González-Ageitos A; Amenedo M; González-Quintas A; Gamazo JL; Togores P; Losada G; Almanza C; Romero C; Gómez-Martín C
    J Chemother; 2003 Apr; 15(2):192-7. PubMed ID: 12797398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
    Valero V
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.